↓ Skip to main content

Dove Medical Press

Resistant mutations in CML and Ph+ALL – role of ponatinib

Overview of attention for article published in Biologics: Targets & Therapy, October 2014
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#39 of 284)
  • High Attention Score compared to outputs of the same age (85th percentile)

Mentioned by

news
1 news outlet
policy
1 policy source

Citations

dimensions_citation
84 Dimensions

Readers on

mendeley
119 Mendeley
Title
Resistant mutations in CML and Ph<sup>+</sup>ALL &ndash; role of ponatinib
Published in
Biologics: Targets & Therapy, October 2014
DOI 10.2147/btt.s50734
Pubmed ID
Authors

Geoffrey D Miller, Benjamin J Bruno, Carol S Lim

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 119 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 <1%
Unknown 118 99%

Demographic breakdown

Readers by professional status Count As %
Researcher 24 20%
Student > Ph. D. Student 15 13%
Student > Bachelor 13 11%
Student > Master 13 11%
Student > Doctoral Student 8 7%
Other 17 14%
Unknown 29 24%
Readers by discipline Count As %
Medicine and Dentistry 30 25%
Biochemistry, Genetics and Molecular Biology 20 17%
Agricultural and Biological Sciences 14 12%
Chemistry 10 8%
Pharmacology, Toxicology and Pharmaceutical Science 3 3%
Other 11 9%
Unknown 31 26%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 July 2020.
All research outputs
#3,415,054
of 25,373,627 outputs
Outputs from Biologics: Targets & Therapy
#39
of 284 outputs
Outputs of similar age
#36,987
of 265,635 outputs
Outputs of similar age from Biologics: Targets & Therapy
#2
of 4 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 86th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 284 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one has done well, scoring higher than 85% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 265,635 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one. This one has scored higher than 2 of them.